Q&A With Paul Kwo From Indiana University: Hepatitis C Treatment Helps Reduce Need for Liver Transplant

It was not long ago that patients with hepatitis C were among the leading candidates for liver transplants. Now that many forms of the disease are curable that attention can be turned to other patients in need.

It was not long ago that patients with hepatitis C were among the leading candidates for liver transplants. Now that many forms of the disease are curable that attention can be turned to other patients in need.

Paul Kwo, MD, from Indiana University discussed how the field has changed in recent years and what it can mean for the treatment of other liver diseases during the American College of Gastroenterology's annual meeting in Hawaii.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.